Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-049919
Filing Date
2021-08-05
Accepted
2021-08-05 16:12:04
Documents
1
Period of Report
2021-08-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4103
  Complete submission text file 0001209191-21-049919.txt   5655
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Issuer) CIK: 0001404644 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21823 30TH DRIVE SE BOTHELL WA 98021
Business Address
DRACHMAN JONATHAN G (Reporting) CIK: 0001588467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 211148302